Emerald Mutual Fund Advisers Trust’s Clovis Oncology, Inc. CLVS Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-324,650	Closed	-$9.54M	–	247
2018 Q3	$9.54M	Buy	324,650 +32,961	+11%	+$1.28M	0.32%	116
2018 Q2	$13.3M	Buy	291,689 +134,274	+85%	+$6.53M	0.48%	86
2018 Q1	$8.31M	Sell	157,415 -41,723	-21%	-$2.43M	0.33%	116
2017 Q4	$13.5M	Sell	199,138 -73,675	-27%	-$5.15M	0.54%	64
2017 Q3	$22.5M	Buy	272,813 +67,164	+33%	+$5.32M	0.94%	28
2017 Q2	$19.3M	Buy	205,649 +77,810	+61%	+$4.76M	0.84%	40
2017 Q1	$8.14M	Buy	+127,839	New	+$7.77M	0.37%	97

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's CLVS Position: Q4 2018 in Review

Emerald Mutual Fund Advisers Trust sold out of Clovis Oncology, Inc. (CLVS) in Q4 2018, closing a stake of 324,650 shares — an estimated $9.54M sold.

Emerald Mutual Fund Advisers Trust first reported a position in CLVS in Q1 2017 and held it in 7 quarters. The position peaked at $22.5M in Q3 2017. 165 funds tracked by Wall St. Rank hold CLVS as of Q4 2018.

Emerald Mutual Fund Advisers Trust reported no remaining Clovis Oncology, Inc. position as of Q4 2018 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 324,650 Clovis Oncology, Inc. shares in Q4 2018, an estimated $9.54M.
Emerald Mutual Fund Advisers Trust first reported a position in Clovis Oncology, Inc. in Q1 2017 and held it in 7 quarters.
Emerald Mutual Fund Advisers Trust's Clovis Oncology, Inc. position peaked at $22.5M in Q3 2017.
165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2018.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2018, filed 30 Jan 2019.